Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms
PHASE3TerminatedINTERVENTIONAL
Enrollment
544
Participants
Timeline
Start Date
September 30, 1999
Primary Completion Date
March 31, 2003
Study Completion Date
March 31, 2003
Conditions
Prostate Cancer
Interventions
DRUG
zoledronic acid
Trial Locations (1)
90095-1781
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles